Home/ Supplements/ Alpha Lipoic Acid/ Micronutrient Capsule

Micronutrient Capsule

product on market Capsule Igennus Healthcare Nutrition Safety: 98/100
98/100

This product looks safe

  • Vitamin B3: 48mg is 1.4× the Tolerable Upper Intake Level (35mg)
  • 71% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula combines antioxidants like N-Acetyl L-Cysteine, Alpha-Lipoic Acid, and Resveratrol, which are supported by moderate evidence for reducing oxidative stress. Vitamin C and B3 provide further cellular support, though overall evidence coverage for this specific blend is limited. The profile maintains a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Vitamin B3: 48mg is 1.4× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for Micronutrient Capsule
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
Other Combinations
Product Type
71%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

N-Acetyl L-Cysteine
100 mg
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
50 mg
Market median: 167.0mg (311 products) 183 studies (A:0, B:65)
Vitamin C
80 mg (100% DV)
48 mg (300% DV)
Exceeds UL by 1.4× (UL: 35 mg) 196 studies (A:5, B:63)
15 mg (150% DV)
1.4× RDA — within safe limits 263 studies (A:6, B:134)
18 mg (300% DV)
3.6× RDA — above typical dose 2 studies — no high-quality reviews
7.98 mg (570% DV)
6.1× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
5.5 mg (500% DV)
4.6× RDA — above typical dose 76 studies (A:0, B:33)
4.5 mg (300% DV)
3.5× RDA — above typical dose 13 studies (A:0, B:1)
110 mcg (200% DV)
2.0× RDA — within safe limits 173 studies (A:0, B:67)
100 mcg (200% DV)
3.3× RDA — above typical dose 27 studies (A:0, B:11)
100 mcg (50% DV)
Within RDA (0.2× RDA) 226 studies (A:10, B:105)
20 mcg (800% DV)
8.3× RDA — above typical dose 139 studies (A:1, B:44)

Other Ingredients

MindCare Protect Micronutrient Capsule
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Warnings & Precautions

Seek professional advice before taking any food supplement if you are taking medication, pregnant or breast-feeding.

This product should not be used as a substitute for a varied and balanced diet and healthy lifestyle.

Keep out of reach of young children.

Formulation Notes

Stay sharp Supports normal brain function & protects against oxidative stress

N-Acetyl L-Cysteine, Alpha-Lipoic Acid, Resveratrol & Micronutrients

For him & her

Daily nutrition to help you stay sharp Effective strategies to delay mental deterioration in later life begin in middle age. The brain requires specific nutrients, together with a good diet and active lifestyle, to stay healthy. MindCare Protect has been formulated with an advanced blend of bioactive nutrients to help adults stay sharp and get the most out of life.

Dual capsule formula for advanced support Vitamins B2, C and E, selenium & zinc protect cells against oxidative stress. Vitamin B5 contributes to neurotransmitter production and supports mental performance. Vitamins B6, B12, C, D3, folate and selenium contribute to the normal functioning of the immune system. B-Vitamins & vitamin C contribute to the normal functioning of the nervous system. Vitamin C contributes to energy release. Zinc contributes to normal cognitive function.

No artificial colours, flavours or preservatives Free from: daily, gluten, lactose, salt, soya, yeast Non-GMO

Not tested on animals

Halal

Kosher

Additional Information

Be kind to your health

Directions for use Take 1 omega-3 EPA & DHA capsule (silver blister) and 1 MindCare Protect micronutrient capsule (green blister) daily with food. Consistent intake is recommended for optimal results. It is not necessary to take a general multivitamin and mineral supplement in addition to MindCare Protect. It is not advisable to exceed the recommended dose.

Store in a cool, dry place away from direct sunlight.

Facebook.com/igennus

Metadata

Product Details

DSLD Entry Date2021-07-27
Product TypeOther Combinations
FormCapsule
DSLD ID249484
Data Updated2026-04-11
Research

Research Evidence

21
Research Sources
52
Avg Quality
13
Rct
4
Meta Analysis
2
Systematic Review
2
Clinical Trial
A Alpha-lipoic acid for diabetic peripheral neuropathy
Systematic Review The Cochrane database of systematic reviews 2024 PubMed DOI
B Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
Rct Nutrients 2024 PubMed DOI
B Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024 PubMed DOI
B Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis
Meta Analysis Medicine 2023 PubMed DOI
C The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Metabolism: clinical and experimental 2018 PubMed DOI
C A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy
Meta Analysis European journal of endocrinology 2012 PubMed DOI
C Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Rct Endocrine, metabolic & immune disorders drug targets 2020 PubMed DOI
C A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
Rct Journal of postgraduate medicine 2024 PubMed DOI
C Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
Systematic Review Canadian journal of diabetes 2024 PubMed DOI
C Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy.
Rct Pakistan journal of pharmaceutical sciences PubMed
View all evidence for Alpha Lipoic Acid →
Compare

Similar Products

View all Alpha Lipoic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.